14-64030045-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_182914.3(SYNE2):​c.6865T>C​(p.Leu2289Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0489 in 1,613,850 control chromosomes in the GnomAD database, including 2,616 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.079 ( 649 hom., cov: 33)
Exomes 𝑓: 0.046 ( 1967 hom. )

Consequence

SYNE2
NM_182914.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.00

Publications

6 publications found
Variant links:
Genes affected
SYNE2 (HGNC:17084): (spectrin repeat containing nuclear envelope protein 2) The protein encoded by this gene is a nuclear outer membrane protein that binds cytoplasmic F-actin. This binding tethers the nucleus to the cytoskeleton and aids in the maintenance of the structural integrity of the nucleus. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SYNE2 Gene-Disease associations (from GenCC):
  • autosomal dominant Emery-Dreifuss muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Emery-Dreifuss muscular dystrophy 5, autosomal dominant
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • left ventricular noncompaction
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 14-64030045-T-C is Benign according to our data. Variant chr14-64030045-T-C is described in ClinVar as [Benign]. Clinvar id is 130505.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.146 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE2NM_182914.3 linkc.6865T>C p.Leu2289Leu synonymous_variant Exon 44 of 116 ENST00000555002.6 NP_878918.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE2ENST00000555002.6 linkc.6865T>C p.Leu2289Leu synonymous_variant Exon 44 of 116 1 NM_182914.3 ENSP00000450831.2 Q8WXH0-2A0A0C4DGK3

Frequencies

GnomAD3 genomes
AF:
0.0793
AC:
12047
AN:
151974
Hom.:
643
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.149
Gnomad AMI
AF:
0.0406
Gnomad AMR
AF:
0.0922
Gnomad ASJ
AF:
0.0493
Gnomad EAS
AF:
0.0519
Gnomad SAS
AF:
0.0382
Gnomad FIN
AF:
0.0620
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0436
Gnomad OTH
AF:
0.0767
GnomAD2 exomes
AF:
0.0584
AC:
14564
AN:
249388
AF XY:
0.0539
show subpopulations
Gnomad AFR exome
AF:
0.149
Gnomad AMR exome
AF:
0.103
Gnomad ASJ exome
AF:
0.0483
Gnomad EAS exome
AF:
0.0526
Gnomad FIN exome
AF:
0.0524
Gnomad NFE exome
AF:
0.0402
Gnomad OTH exome
AF:
0.0518
GnomAD4 exome
AF:
0.0457
AC:
66861
AN:
1461758
Hom.:
1967
Cov.:
36
AF XY:
0.0452
AC XY:
32846
AN XY:
727166
show subpopulations
African (AFR)
AF:
0.152
AC:
5087
AN:
33478
American (AMR)
AF:
0.103
AC:
4619
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0458
AC:
1198
AN:
26132
East Asian (EAS)
AF:
0.0567
AC:
2251
AN:
39686
South Asian (SAS)
AF:
0.0391
AC:
3375
AN:
86250
European-Finnish (FIN)
AF:
0.0510
AC:
2723
AN:
53408
Middle Eastern (MID)
AF:
0.0324
AC:
187
AN:
5766
European-Non Finnish (NFE)
AF:
0.0399
AC:
44398
AN:
1111928
Other (OTH)
AF:
0.0501
AC:
3023
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3633
7266
10900
14533
18166
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1750
3500
5250
7000
8750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0794
AC:
12072
AN:
152092
Hom.:
649
Cov.:
33
AF XY:
0.0790
AC XY:
5876
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.149
AC:
6194
AN:
41454
American (AMR)
AF:
0.0921
AC:
1408
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0493
AC:
171
AN:
3470
East Asian (EAS)
AF:
0.0521
AC:
270
AN:
5186
South Asian (SAS)
AF:
0.0382
AC:
184
AN:
4814
European-Finnish (FIN)
AF:
0.0620
AC:
656
AN:
10574
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0436
AC:
2965
AN:
67992
Other (OTH)
AF:
0.0773
AC:
163
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
533
1067
1600
2134
2667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0567
Hom.:
295
Bravo
AF:
0.0837
Asia WGS
AF:
0.0550
AC:
191
AN:
3476
EpiCase
AF:
0.0382
EpiControl
AF:
0.0398

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Emery-Dreifuss muscular dystrophy 5, autosomal dominant Benign:2
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
4.9
DANN
Benign
0.65
PhyloP100
-1.0
Mutation Taster
=294/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11850509; hg19: chr14-64496763; API